# Nasal Naloxone for Narcotic Overdose

> **NCT01912573** · PHASE4 · UNKNOWN · sponsor: **Judith Feinberg** · enrollment: 236 (estimated)

## Conditions studied

- Drug Overdose

## Interventions

- **DRUG:** Intranasal (IN) naloxone
- **DRUG:** Intravenous (IV) naloxone
- **DRUG:** Intramuscular (IM) naloxone
- **DRUG:** Intraosseus (IO) naloxone

## Key facts

- **NCT ID:** NCT01912573
- **Lead sponsor:** Judith Feinberg
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09
- **Primary completion:** 2014-09
- **Final completion:** 2015-03
- **Target enrollment:** 236 (ESTIMATED)
- **Last updated:** 2013-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01912573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01912573, "Nasal Naloxone for Narcotic Overdose". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01912573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*